IMDELLTRA (AMG757)
Tarlatamab-dlle · KIT · Amgen, Inc
No Recall History
Plain English
IMDELLTRA (AMG757) is a kit containing tarlatamab-dlle. Manufactured by Amgen, Inc.
Key Facts
- Brand Name
- IMDELLTRA (AMG757)
- Generic Name
- Tarlatamab-dlle
- NDC Code (Product)
55513-059- Manufacturer
- Amgen, Inc
- Dosage Form
- KIT
- Marketing Status
- Application #
- BLA761344
- Marketing Start
- 05/16/2024
Recall History
No Recall HistoryFrequently Asked Questions
What is IMDELLTRA (AMG757) used for?
IMDELLTRA (AMG757) contains Tarlatamab-dlle. It is a kit taken as directed. Consult your doctor for specific uses.
Is IMDELLTRA (AMG757) a controlled substance?
IMDELLTRA (AMG757) is not classified as a controlled substance by the DEA.
What is the generic name for IMDELLTRA (AMG757)?
The generic name for IMDELLTRA (AMG757) is Tarlatamab-dlle. There are no other listed brand versions of Tarlatamab-dlle.
What is the NDC code for IMDELLTRA (AMG757) ?
The NDC (National Drug Code) for IMDELLTRA (AMG757) is 55513-059, listed by Amgen, Inc.
Other IMDELLTRA (AMG757) Dosages
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)